Benjamin Stone
Chief Business Officer at First Tracks Biotherapeutics, Inc. (TRAX) since April 2026
Benjamin Stone has filed 6 insider reports with the SEC since April 2026, as chief Business Officer at First Tracks Biotherapeutics, Inc. (TRAX). The latest filing, on November 3, 2026, reports grant or award at First Tracks Biotherapeutics, Inc. (TRAX).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Benjamin Stone is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Business Officersince April 2026 | 17,262 | $44.46 | Nov 3, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 1, 2026TRAXChief Business Officer Stone Benjamin was granted 42,500 sharesForm 4Grant or award
- Aug 15, 2026TRAXSEC Form 4 filed by Chief Business Officer Stone BenjaminForm 4Grant or award
- Apr 20, 2026TRAXAmendment: SEC Form 3 filed by new insider Stone BenjaminForm 3/ANew insider
- Aug 2, 2026TRAXSEC Form 4 filed by Chief Business Officer Stone BenjaminForm 4Grant or award
- May 12, 2026TRAXSEC Form 4 filed by Chief Business Officer Stone BenjaminForm 4Grant or award
- Apr 20, 2026TRAXBenjamin Stone became an insiderForm 3New insider
Compare Benjamin Stone with
- Benjamin Stone vs Ajim Tamboli1 shared
- Benjamin Stone vs Daniel Faga1 shared
- Benjamin Stone vs Paul F. Lizzul1 shared
- Benjamin Stone vs John A Orwin1 shared
- Benjamin Stone vs J. Anthony Ware1 shared
- Benjamin Stone vs John P. Schmid1 shared
Other insiders at the same companies
- Ajim TamboliTRAX
- Daniel FagaTRAX
- Paul F. LizzulTRAX
- John A OrwinTRAX
- J. Anthony WareTRAX
- John P. SchmidTRAX
- Magda MarquetTRAX
- Rita JainTRAX
- Dennis M FentonTRAX
- EcoR1 Capital, LLCTRAX
- Anaptysbio, IncTRAX
Questions about Benjamin Stone
- What is Benjamin Stone's role at First Tracks Biotherapeutics, Inc.?
- Benjamin Stone reports to the SEC as chief Business Officer at First Tracks Biotherapeutics, Inc. (TRAX), according to the latest filing on November 3, 2026.
- How many shares does Benjamin Stone own?
- After the latest filing that states it, Benjamin Stone directly owned 17,262 shares of First Tracks Biotherapeutics, Inc. (TRAX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Benjamin Stone bought or sold stock recently?
- No open-market purchases or sales by Benjamin Stone are on file. The filings report grant or award.
- How do I get alerts when Benjamin Stone files?
- Follow Benjamin Stone on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Benjamin Stone filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Benjamin Stone (SEC CIK 0002128786). Totals count each trade once, skipping amendments whose original is on file, from Apr 22, 2026 on. View on SEC EDGAR · Get this as JSON